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ABSTRACT 
Nitrogen-based tetracyclic ortho-quinones (naphtho[1'2':4.5]imidazo[1,2-a]pyridine-5,6-diones, NPDOs) and 
their nitro-substituted derivatives (nitro-(P)NPDOs) were obtained by condensation of substituted 2,3-dichloro-
1,4-naphthoquinones with 2-amino-pyridine and -pyrimidine and nitration at an elevated temperature. The struc-
tural features of the compounds as well as their global and regional electrophilic potency were characterized by 
means of DFT computation. The compounds were highly reactive substrates of single- and two-electron (hydride) 
- transferring P-450R (CPR; EC 1.6.2.4) and NQO-1 (DTD; EC 1.6.99.2), respectively, concomitantly producing 
reactive oxygen species. Their catalytic efficiency defined in terms of the apparent second-order rate constant 
(kcat/KM (Q)) values in P-450R- and NQO-1-mediated reactions varied in the range of 3-6 × 107 M-1 s-1 and 1.6-7.4 
× 108 M-1 s-1, respectively. The cytotoxic activities of the compounds on tumor cell lines followed the concentra-
tion-dependent manner exhibiting relatively high cytotoxic potency against breast cancer MCF-7, with CL50 values 
of 0.08-2.02 µM L-1 and lower potency against lung cancer A-549 (CL50 = 0.28-7.66 µM L-1). 3-nitro-pyrimidino-
NPDO quinone was the most active compound against MCF-7 with CL50 of 0.08 ± 0.01 µM L-1 (0.02 µg mL-1)) 
which was followed by 3-nitro-NPDO with CL50 of 0.12 ± 0.03 µM L-1 (0.035 µg mL-1)) and 0.28 ± 0.08 µM L-1 
(0.08 µg mL-1) on A-549 and MCF-7 cells, respectively, while 1- and 4-nitro-quinoidals produced the least cyto-
toxic effects. Tumor cells quantified by AO/EB staining showed that the cell death induced by the compounds 
occurs primarily through apoptosis.  
 
Keywords: heterocycle quinones, ortho-quinones, enzymatic reactivity, antitumor activity, apoptosis, DFT 
computation 
 
 
INTRODUCTION 
Quinones constitute an important class of 
naturally occurring compounds which play a 
pivotal role in the diverse biological systems 
(Nohl et al., 1986; Monks et al., 1992; Bolton 
et al., 2000; Monks and Jones, 2002). They 
also represent a large class of redox active 
xenobiotics which may induce a variety of 
hazardous effects including cardiotoxicity, 
neurotoxicity, immunotoxicity and carcino-
genesis (Bolton et al., 2000; Monks and 
Jones, 2002; Bolton and Dunlap, 2017, and 
refs. therein). On the other hand, quinoid 
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compounds are widely used for treatment of 
viral and microbial infections, and comprise 
one of the major classes of chemotherapeutic 
agents (Riffel et al., 2002; Asche, 2005; 
Garuti et al., 2007, and refs. therein). Owing 
to electrophilic (electron-accepting) capacity 
of quinones, one of the primary stages of their 
(cyto)toxic and/or therapeutic action is related 
to their bioreductive activation mediated by 
oxidoreductases producing semiquinone radi-
cal and/or hydroquinone (diol) species 
(Rooseboom et al., 2004; Siegel et al., 2012). 
The single-electron reduction of quinones is 
typically catalyzed by single-electron trans-
ferring flavoenzymes such as NADPH-cyto-
chrome P-450 reductase (P-450R, CPR), 
NADH-cytochrome b5 reductase (CB5R), 
NADPH:ubiquinone oxidoreductase (comp-
lex I), etc. (Bachur et al., 1979; Ross et al., 
1996; Čėnas et al., 1994; Matsuda et al., 2000; 
Rooseboom et al., 2004, and refs. therein). 
The semiquinone radicals formed are readily 
back-oxidized by molecular oxygen (the so- 
called futile redox cycling) generating super-
oxide along with other reactive oxygen spe-
cies (ROS) (Powis, 1989; Rooseboom et al., 
2004). The obligatory two-electron (hydride) 
reduction of quinones to their diol forms, typ-
ically mediated by two-electron transferring 
flavoenzyme NAD(P)H: quinone acceptor 
oxidoreductase (DT-diaphorase (DTD), 
NQO-1), affords the protection against cyto-
toxic effects of quinones diverting them from 
their redox cycling (Joseph et al., 2000). 
NQO-1 is well-known for being a major xe-
nobiotic metabolizing enzyme, whose induc-
tion is frequently associated with the protec-
tion against toxic and/or carcinogenic effects 
of a large variety of electrophiles. On the 
other hand, the two-electron reduction of cer-
tain structure quinoid xenobiotics and drug 
agents to unstable diol species is accompanied 
by their chemical rearrangement to highly re-
active intermediates and/or spontaneous auto-
oxidation generating ROS (Gutierrez, 2000; 
Beall and Winski, 2000; Colucci et al., 2008; 
Rooseboom et al., 2004; Siegel et al., 2012; 
Bian et al., 2014, 2015). Because of the en-
hanced expression of NQO-1 in tumors and 
tumor cells, this enzyme has become one of 
the most attractive targets for bioreductive ac-
tivation of various redox active xenobiotics 
and drug agents including quinoid-based 
compounds (Danson et al., 2004; Rooseboom 
et al., 2004, Siegel et al., 2012; Bian et al., 
2014, 2015 and refs. therein). The quinone-
mediated enhanced generation of ROS was 
proved to contribute to the "non-specific" cel-
lular damage and/or induction of specific 
ROS-sensing signaling pathways thus caus-
ing cell cycle arrest, senescence, apoptosis 
and other events (Mates and Sanchez-
Jimenez, 2000; Liou and Storz, 2010, and 
refs. therein).  
Among a broad variety of quinoid-based 
compounds, the natural and synthetic hetero-
cyclic quinones were shown to be efficient 
enzymatic substrates and potential cyto-
toxic/anti-tumor agents (Pan et al., 1993; 
Rooseboom et al., 2004; Deegan et al., 2006; 
Colucci et al., 2008; Garuti et al., 2007; Val-
derrama et al., 2008; Chen and Hu 2009; Vás-
quez et al., 2010; Koyama et al., 2010, 2011; 
Brandy et al., 2012; Delgrado et al., 2012; 
Zhang et al., 2012; Bian et al., 2014, 2015; 
Cai et al., 2016). Compared to the heterocy-
clic para-quinoidals, the enzymatic reactivity 
and/or cytotoxic/antitumor activity studies of 
ortho-quinoid compounds are still limited to a 
few groups of the natural and synthetic ortho-
quinoid compounds such as 9,10-phenanthro-
line-5,6-dione (phendione, PD) (Deegan et 
al., 2006), pyrroloquinoline quinone (PQQ) 
(Shen et al., 2009; Shankar et al., 2010), tet-
rahydropyran-fused ortho-napthoquinone (-
lapachone) and its ortho-quinone analogues 
(Bian et al., 2014, 2015, and refs. therein), tet-
rahydrophenanthrofuran-diones (tanshinon-
es) (Zhang et al., 2012; Dang et al., 2011; Cai 
et al., 2016, and refs. therein). The ortho-quin-
oid compounds have proved to be in general 
more effective electrophilic and redox active 
agents than para-quinoid compounds due to 
the enhanced electrophilic character of the 
vicinal carbonyl moieties of the former com-
pounds (Tonholo et al., 1998; Campodonico 
et al., 2009; Borges et al., 2014).  
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Herein we report the study of enzymatic 
reactivity and antitumor activity of the syn-
thesized fused N-containing tetracyclic ortho-
quinoid compounds (naphtho[1'2':4.5] imid-
azo[1,2-a]pyridine-5,6-diones, (P)NPDOs) 
and their nitrated derivatives. The chemical 
structures of the compounds are given in Fig-
ure 1 (for NPDO compounds, the numbers de-
note the relative positions of the nitro groups). 
Their structural features as well as the global 
and the regional (fractional) electrophilic po-
tencies were characterized by means of DFT 
computation. Their enzymatic reduction reac-
tions and redox cycling ability were assessed 
applying single-electron transferring P-450R 
(CPR) and two-electron-transferring NQO-1 
(DTD) as the main flavoenzymes being re-
sponsible for bioreductive activation of a 
large variety of redox active xenobiotics in-
cluding nitroaromate- and quinoid-based 
compounds. The cytotoxic activities of 
(P)NPDO and nitro-(P)NPDO quinoidals 
were estimated against the human A-549, 
MCF-7 and HL-60 tumor cell lines.  
 
MATERIALS AND METHODS 
General 
All chemical reagents and solvents were 
obtained from commercial suppliers (Sigma-
Aldrich (St. Louis, MO, USA), TCI-Europe 
(Zwijdrecht, Belgium) and Merck (Darm-
stadt, Germany)). The purity of the com-
pounds was checked by TLC (silica gel 60 
F254 aluminium plates (Merck, Darmstadt, 
Germany)) and visualized by UV light. The 
flash column chromatography was performed 
by silica gel Wakogel C-200 (Wako Chemi-
cal, Osaka, Japan). The melting points were 
defined in open capillaries by using MEL-
TEMP equipment (Barnstead Thermolyne 
Corp, Dubuque, IA, USA). UV-VIS spectra 
were obtained by Lambda 25 UV-VIS (Per-
kin-Elmer, Waltham, MA, USA) spectropho-
tometer. IR spectra were recorded in KBr on 
a Perkin-Elmer spectrophotometer (FT-IR 
Spectrum BX II). NMR spectra were obtained 
with Bruker spectrometer (1H - 400 MHz and 
13C - 100 MHz) in d-chloroform or d6-DMSO 
by using residual solvent signal as an internal 
standard. HRMS spectra were recorded by 
Dual-ESI Q-TOF 6520 (Agilent Technolo-
gies, Santa Clara, CA, USA) mass spectrom-
eter. 
 
Synthesis  
Naphtho[1‘,2‘:4,5]imidazo[1,2-a]pyridi-
ne-5,6-dione (NPDO), 9-nitro-NPDO, and 
naphtho[1‘,2‘:4,5]imidazo[1,2-a]pyrimidine-
5,6-dione (PNPDO) were synthesized by con-
densation of 2,3-dichloro-1,4-naphthoqui-
none (0.01 M) with 2-amino-N-heterocycles 
(0.02 M) in dry 2-butanol (300 mM) (Figure 
2). The reaction mixture was stirred under ar-
gon and heated at 100 °C in a closed vessel 
for 36 h (for synthesis of 9-nitro-NPDO, the 
time was increased to 96 h). The reaction mix-
ture was concentrated, allowed to cool to 
10 °C, filtered and washed with cold 1-propa-
nol (3x20 ml), hexane, and dried. The result-
ant products were re-crystallized from 1,2-di-
chlorobenzene or purified by flash chroma-
tography (CH3OH/CH2Cl2 (1/10)). 
 
 
 
Figure 1: Chemical structures of N-tetracyclic ortho-quinoidals and their nitrated derivatives used in this 
work: A) NPDOs and B) pyrimidino-NPDOs (PNPDOs) 
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Figure 2: The condensation of 2,3-dichloro-1,4-naphthoquinone with 2-amino-N-heterocycles to obtain 
NPDO quinoids ( X=CH, R=H), 9-nitro-NPDO ( X=CH, R= NO2) and pyrimidine-NPDO (X=N, R=H) com-
pounds 
 
 
 
3-Nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-
a] pyridine-5,6-dione (3-nitro-NPDO), and 3-
nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-a] py-
rimidine-5,6-dione (3-nitro-PNPDO) were 
obtained by the nitration reactions of NPDO 
and pyrimidino-NPDO (PNPDO) quinoids, 
applying fuming nitric acid in 98 % H2SO4 at 
reflux. 1 g (4 mM) pymd-NPDO was added to 
the stirred ice-cold mixture of 0.8 ml 95 % 
HNO3 and 25 ml 98 % H2SO4, heated to 
110 °C and refluxed for 3 h, then allowed to 
cool to room temperature and poured on 200 g 
of ice. The precipitate was filtered, washed by 
5 % sodium hydrocarbonate solution and sub-
sequently by distilled water to the neutral re-
action. After drying, the final product, re-
crystallized from CH2Cl2, yielded a small red 
crystalline powder. 
1- and 4-nitro-naphtho[1‘,2‘:4,5] imida-
zo [1,2-a]pyridine-5,6-diones (1- and 4-nitro-
NPDOs) were synthesized by condensation 
reaction of 5-nitro-2,3-dichloro-1,4-naphtho-
quinone (NCNQ) with 2-aminopyridine dur-
ing the prolonged heating in a polar solvent 
(Figure 3). 2-Aminopyridine (1.88 g, 20 mM) 
was slowly added to the stirred NCNQ solu-
tion (2.27 g, 10 mM) in dry 1-butanol 
(200 ml). The suspension was stirred under 
argon and heated at 110 °C for 56 h, then con-
centrated and allowed to cool to 5 °C. The ob-
tained product was filtered and washed with 
cold methanol (3x20 ml), then hexane, and 
dried. The resultant mixture of 1-nitro- and 4-
nitro-NPDO isomers was fractionally crystal-
lized from hot chloroform, producing two 
crystal fractions, which were purified by flash 
chromatography on SiO2 with ethyl acetate. 
After re-crystallization, the more and less sol-
uble fractions yielded 1-nitro- and 4-nitro-
NPDO isomers, respectively, with molar ratio 
of 1:3. 
 
 
Figure 3: The synthesis of 1- and 4-nitro-NPDOs by condensation reaction of 2-amino-pyridine with 5-
nitro-2,3-dichloro-1,4-napthoquinone (110 °C/56 h)
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Characterization 
Naphtho[1‘,2‘:4,5]imidazo[1,2-a]pyridi-
ne-5,6-dione (NPDO). Orange solid. Yield: 
43%. Melting point: 304-305 °C. UV-Vis 
λmax (nm): 216, 242, 261, 283, 295, 396. FT-
IR (KBr): ν (cm-1) 1687, 1651 (C═O), 1629, 
1602, 1498, 1482, 1418, 1326, 1257, 1197, 
1151, 1089, 927, 899, 766, 723, 699, 622, 
576. 1H-NMR (d6-DMSO): δ (ppm) 9.25 (d, 
1H, H-8, JH8-H9=5.00 Hz) 8.12 (d, 1H, H-10, 
JH9-H10=5.00 Hz) 7.70, 7.46 (2m, 4H, H-1, H-
2, H-3, H-4) 7.14 (m, 1H, H-9). 13C-NMR 
(CDCl3): δ (ppm) 181.82 (1C, C-5) 169.33 
(1C, C-6) 155.58 (1C, Cquat) 150.56 (1C, 
Cquat) 135.74 (1C, C-2) 131.71 (1C, Cquat) 
131.32 (1C, C-10) 130.79 (1C, C- Cquat) 
130.55 (1C, C-3) 130.00 (1C, C-4) 128.73 
(1C, Cquat) 126.72 (1C, C-8) 124.75 (1C, C-
1) 118.03 (1C, C-11) 116.65 (1C, C-9). 
HRMS: λmaxm/z [M+H]+. 249.0652, (calc.: 
249.0657). 
Naphtho[1‘,2‘:4,5]imidazo[1,2-a]pyrimi-
dine-5,6-dione (PNPDO). Bright yellow 
solid. Yield: 17 %. Melting point: 345 °C. 
UV/ Vis λmax (nm): 241, 263, 293. FT-IR 
spectrum ν (cm-1): 3049, 3066, 1700, 1654, 
1610, 1540, 1523, 1479, 1423, 1396, 1375, 
1347, 1241, 1220, 1186, 1153, 1119, 1073, 
1014, 938, 920, 887, 850, 832, 815, 784, 757, 
736, 723, 696, 669, 648, 610, 578. 1H-NMR 
(CDCl3): δ (ppm) 9.53 (dd, 1H, H-8, J JH8-
H9=6.41 Hz) 8.88 (d, 1H, H-10, JH1-H2 =7.93 
Hz) 8.36 (dd, 2H, H-1, H-4, JH3-H4=9.16 Hz), 
7.75 (m, 2H, H-2, H-3), 7.27 (t, 1H, H-9, JH8-
H9=JH9-H10=6.09 Hz). 13C-NMR (CDCl3): δ 
(ppm) 187.68 (1C, C-5), 182.16 (1C, C-6) 
177.00 (1C, Cquat) 150.16 (1C, Cquat) 
149.40 (1C, Cquat) 144.90 (1C, C-4) 136.06 
(1C, C-2) 132.86 (1C, C-10) 130.84 (1C, 
Cquat) 130.82 (1C, Cquat) 129.17 (1C, C-8) 
126.99 (1C, C-1) 124.54 (1C, C-3) 117.40 
(1C, C-9). HRMS: (C14H6N4O4): 
[M+H]+.:250.0608 (found), 250.0611(calc.). 
3-Nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-
a]pyridine-5,6-dione (3-nitro-NPDO). Red 
solid. Yield: 57 %. Melting point >360 °C. 
FT-IR spectrum ν (cm-1): 1702, 1651 (C═O), 
1628, 1609, 1544, 1521 (NO2), 1504, 1409, 
1348, 1325, 1287, 1245, 1210, 1191, 1153, 
1115, 1072, 1010, 942, 910, 736. 1H-NMR 
(DMSO-d6): δ (ppm) 9.36 (d, 1H, H-8, JH8-
H9=7.62 Hz) 8.96 (s, 1H, H-4) 8.57 (d, 1H, H-
1, JH1-H2= 8.54 Hz) 8.43 (d, 1H, H-2, JH1-
H2=8.54 Hz) 7.93 (d, 1H; H-11, JH10-H11=7.63 
Hz) 7.75 (t, 1H, H-10, JH9-H10=JH10-H11=7.63 
Hz) 7.32 (t, 1H, H-9, JH8-H9 =JH9-H10 =7.63 
Hz). HRMS m/z [M+H]+. 294.0505 (calc.: 
294.0509). 
9-Nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-
a]pyridine-5,6-dione (9-nitro-NPDO). Re-
dish orange solid. Yield: 11 %. M.p. 342-3 °C 
(with decomposition). FT-IR (KBr): ν (cm-1) 
1694, 1652 (C=O), 1640, 1599, 1551, 1513, 
1413, 1344, 1304, 1270, 1240, 1220, 907, 
822. 1H-NMR (CDCl3): δ (ppm) 9.45 (s, 1H, 
H-8) 8.17, 7.62 (2m, 4H, H-1, H-2, H-3, H-4) 
7.75 (dd, 1H, H-11, JH10-H11=9.6 Hz, JH8-
H11=0.73 Hz) 7.58 (dd, 1H, H-10, JH10-H11=9.6 
Hz, JH8-H10=2.06 Hz). 13C-NMR (CDCl3): δ 
(ppm) 182.13 (1C, C-5), 164.04 (1C, C-6), 
155.40 (C-quat), 135.6 (1C, C-3) 133.5 (1C, 
C-4) 131.10 (1C, C-8) 127.8 (1C, C-1) 122.3 
(1C, C-11) 114.4 (1C, C-9). HRMS m/z 
[M+H]+ 294.0512 (calc.: 294.0509).  
1-nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-
a]pyridine-5,6-dione (1-nitro-NPDO). Or-
ange red solid. Yield: 17 %, m.p. 292 °C. UV/ 
Vis spectrum (nm): 240, 296, 398. FT-IR (cm-
1): 3080, 1701, 1654, 1601, 1539, 1497, 1445, 
1415, 1405, 1377, 1320, 1285, 1244, 1218, 
1186, 1145, 1003, 929, 905, 868, 833, 768, 
750, 715, 699. 1H NMR: (400 MHz, d-chlo-
roform): δ (ppm) 9.34 (d, 1H, H-8, JH8-
H9=6,43Hz); 8.32 (d. 1H, H-2, JH2-H3 =7.85Hz; 
7.87 (m. 3H, H-2, H3, H-11); 7.74 (t. 1H, H-
10, JH9-H10=JH10-H11=7.76Hz); 7.54 (d, 1H, H-
4, JH3-H4=7.95Hz); 7.31 (t, 1H, H-9, JH8-
H9=JH9-H10=6. 24Hz). 13C-NMR (100 MHz, d-
chloroform) ): δ (ppm) 190.20, 184.52, (2C, 
C-5, C-6), 175.06 (1C, Cquat), 141.92 (1C, C-
1), 133.02 (1C, C-2), 130.67 (1C, C-10), 
126,85 (1C, C-8), 125.10 (1C, C-4), 122,36 
(1C, C-3), 117.11 (1C, C-11), 116.71 (1C, C-
9). HRMS: (C15H7N3O4) [M+H]+.: 294.0510 
(found), 294.0509 (calc.).  
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4-nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-
a]pyridine-5,6-dione (4-nitro-NPDO). Red 
solid. Yield 21 %, m.p. 323 °C. UV/ Vis spec-
trum (nm): 241, 264, 297, 400. FT-IR (cm-1): 
3073, 3038, 1695, 1652, 1602, 1541, 1498, 
1474, 1450, 1416, 1371, 1325, 1285, 1256, 
1240, 1218, 1185, 1256, 1241, 1218, 1186, 
1150, 1110, 1006, 931, 905, 826, 806, 771, 
718, 703, 686, 574. HRMS: (C15H7N3O4) 
[M+H]+.: 294.0508 (found), 294.0509 (calc.) 
1H NMR: (400 MHz, d-chloroform): δ (ppm) 
9.29 (d, 1H, H-8, JH8-H9=6,40Hz); 8.42 (d. 1H, 
H-10, JH10-H11=JH9-H10 =7.94Hz; 7.83 (m. 2H, 
H-11); 7.74 (t. 1H, H-10, JH9-H10=JH10-
H11=7.64Hz); 7.51 (d, 1H, H-3, JH3-
H4=7.95Hz); 7.27 (t, 1H, H-9, JH8-H9=JH9-
H10=6.12Hz). 13C-NMR (100 MHz, d-chloro-
form) ): δ (ppm) 187.74, 192.19 (2C, C-5, C-
6), 177.02 (1C, Cquat), 144.95 (1C, C-4), 
136.12 (1C, C-2), 132.98 (1C, C-10), 129,21 
(1C, C-8), 127.13 (1C, C-1), 124,56 (1C, C-
3), 118.63 (1C, C-11), 117.41 (1C, C-9).  
3-nitro-naphtho[1‘,2‘:4,5]imidazo[1,2-
a]pyrimidine-5,6-dione (3-nitro-PNPDO).  
UV/Vis spectrum λmax (nm): 239, 319, 
430. FT-IR spectrum (cm-1): 3049, 3066, 
1702, 1654, 1610, 1540, 1523, 1479, 1423, 
1396, 1375, 1347, 1241, 1220, 1186, 1153, 
1119, 1073, 1014, 938, 920, 887, 850, 832, 
815, 784, 757, 736, 723, 696, 669, 648, 610, 
578. 1H-NMR (d-chloroform): δ (ppm) 9.58 
(dd, 1H, H-8, J JH8-H9=6.43 Hz) 8.93 (s, 1H, 
H-4) 8.36 (dd, 2H, H-1, H-4, JH1-H2=9.13 Hz), 
7.83 (m, 2H, H-2, H-4), 7.27 (t, 1H, H-9, JH8-
H9=JH9-H10=6.43 Hz). 13C-NMR (d-
chloroform): δ (ppm) 188.18 (1C, C-5), 
183.23 (1C, C-6) 179.40 (1C, Cquat) 153.04 
(1C, Cquat) 147.18 (1C, Cquat) 145.98 (1C, 
C-4) 138.46 (1C, C-2) 133.89 (1C, C-10) 
132.54 (1C, Cquat) 131.12 (1C, Cquat) 
129.96 (1C, C-8) 127.19 (1C, C-1) 125.23 
(1C, C-3) 119.10 (1C, C-9). HRMS: 
(C14H6N4O4): [M+H]+. : 295.0460 (found), 
295.0462 (calc.)  
 
Computational details 
The quantum mechanical computation of 
the compounds was performed by Spartan 10' 
(Wavefunction Inc., version 1.1.0, 2011, Ir-
vine, CA, USA) software package. Their ge-
ometries were initially refined by the mechan-
ical MMFF94 method and further optimized 
by the semi-empirical PM6 method. The final 
reoptimization and computation of the com-
pounds were performed by DFT-B3LYP 
functional with 6-31+G (d) basis set. The ge-
ometries of the compounds were globally op-
timized without symmetry constraints and 
their stationary points were confirmed by vi-
brational frequency analysis. The electron af-
finity (EA) of the compounds was assessed as 
the Gibbs' energy difference between their op-
timized neutral and anion free radical states 
(at 298.15 K). The cDFT-based global reac-
tivity indices of the compounds were calcu-
lated applying their LUMO and HOMO ei-
genvalues, and their regional electrophilic re-
activity was assessed in terms of the electro-
philic Fukui function (f +) values by using the 
single-point FMO approach (Contreras et al., 
1999) employing the PYTHON scripting lan-
guage.  
 
Enzymes and enzymatic assay 
NADPH:cytochrome P-450 reductase 
(CPR; EC 1.6.2.4) was purified by the method 
described in Pechurskaja et al. (2007), and its 
concentrations was quantified spectrophoto-
metrically at 455 nm (Δε456 = 21.4 mM-1  
cm-1). NAD(P)H: quinone oxidoreductase 
(DTD, NQO1; EC 1.6.99.2) was purified by 
the established method (Prochaska, 1988), 
and its concentration was quantified at 460 
nm applying Δε460 = 11.0 mM-1 cm-1. Bovine 
cytochrome c, superoxide dismutase (SOD; 
EC 1. 15.1.1) and catalase (CAT; EC 
1.11.1.6) were obtained from suppliers 
(Sigma-Aldrich (Saint Louis, MO, USA)).  
The enzymatic reactivity of the com-
pounds was measured spectrophotometrically 
by Carry-60 spectrophotometer (Agilent 
Technologies) in 0.1 M K-phosphate buffer 
(pH 7.0) containing 1 mM EDTA, at 25 °C. 
The enzymatic rates were defined according 
to NADPH oxidation at 340 nm (Δε340 = 6.22 
mM−1 cm−1) and corrected for the auto-oxida-
tion of the enzymes in the absence of quinoid 
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substrates (0.11 s-1 and 0.05 s-1 for CPR and 
DTD, respectively). Typically, 10-15 concen-
trations of the compounds were used, and 
each measurement was performed in tripli-
cate. In separate experiments, quinone-medi-
ated single-electron reduction of 50 µM fer-
ricytochrome c was monitored 
spectrophotometrically at 550 nm (Δε550 = 
20.0 mM-1 cm-1), and O2 uptake was recorded 
polarographically applying a Clark electrode 
(Digital Model 10, Rank Brothers Ltd., Cam-
bridge, UK), at 25 °C. 
 
Assessment of kinetic parameters 
The apparent turnover number (kcat) and 
the apparent Michaelis constant (KM,Q) values 
were obtained by using Michaelis-Menten 
equation of v0/[E0] (s-1) vs. [Q], where v0, [E0] 
and [Q] denote the enzymatic rate, the total 
enzyme concentration, and the concentration 
of the compound, respectively. The apparent 
second-order rate constant (kcat/KM,Q ) values 
were calculated applying the re-parameter-
ized form of Michaelis-Menten equation 
(Kolm et al., 1995; Šarlauskas et al., 2016). 
 
Tumor cell lines and cell viability assay  
Human pulmonary epithelial A-549 and 
breast tumor MCF-7 cells were cultured in 
DMEM media (Life Technologies, USA), 
containing 10 % (v/v) fetal bovine serum 
(Life Technologies, USA), 100 U/ml penicil-
lin, and 100 μg/ml streptomycin (Biological 
Industries, Israel), in a humidified atmosphere 
with 5 % CO2 at 37 °C. The adherent cells 
were detached by 0.25 % trypsin-EDTA. The 
target cells, at density of 2 × 105/ml, were 
seeded into 96-well plates to adhere for 24 h. 
After reaching 60–80 % confluence, they 
were treated by the compounds for 24 h. Cell 
survival was quantified by colorimetric assay 
based on the conversion of MTT to MTT-
formazan product. The stock solutions of the 
compounds were prepared in DMSO (0.1 % 
(v/v) in culture media). After the 24 h treat-
ment with the compounds, the cells were 
washed twice with 0.1 M PBS, and MTT so-
lution (0.2 mg/ml PBS) was added. Following 
1 h incubation at 37 °C, the overlying media 
was removed, and formazan crystals were dis-
solved by 96 % EtOH. The absorbance den-
sity was measured at 570 nm (Varioskan 
Flash microplate spectrophotometer; Thermo 
Scientific, USA). At least three independent 
experiments were performed for each concen-
tration of the compounds and the cell survival 
was assessed as a percentage in respect to 
0.1 % DMSO-treated cells. The CL50 values 
were defined by using a four-parameter lo-
gistic equation (SigmaPlot software, Inc., San 
Jose, CA).  
 
Double fluorescence Acridine Orange 
(AO)/Ethidium Bromide(EB) staining  
The type of cell death was assessed by 
means of the double AO/EB fluorescence 
staining. After 24 h treatment by ortho-
quinoid compounds at their CL50 concent-
rations, the cells were washed with PBS, 
stained with AO (100 μg/ml in PBS) and EB 
(100 μg/ml in PBS) and analysed by 
fluorescence microscope (Olympus IX51, 
Japan). 0.1 % DMSO-treated cells served as a 
negative contol.  
 
RESULTS AND DISCUSSION 
The computational study 
The quantum mechanical computation 
showed that the structures of optimized tetra-
cyclic systems of NPDO and PNPDO quin-
oids have a planar geometry and the orienta-
tion of the nitro groups depends on the posi-
tions of their attachment. The nitro groups at-
tached at the 3 and 9 positions of 3- and 9-
nitro-quinoids were almost parallel to the tet-
racyclic plane, pointing to their electron-at-
tracting -inductive and -resonance effects, 
while the dihedral angles of the nitro groups 
introduced at the 1 and 4 positions were de-
fined to be almost at the perpendicular orien-
tation ( ~89o), thus pointing to their elec-
tron-attracting inductive effects. Note that the 
close dihedral angle of the nitro group was de-
fined for 4-nitro-NPDO quinone by means of 
the X-ray diffraction analysis ( ~84o) (un-
published data). The twisting of the nitro 
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groups is most likely to be caused by the re-
pulsive interaction of the lone electron pair of 
the nitrogen atom (N-12) of the tetracyclic 
system with the oxygen atom of the nitro 
group attached to position 1 in the 1-nitro-
quinoid compound, and by the repulsive inter-
action of the oxygen atom of quinoid moiety 
with the oxygen atom of the nitro group added 
to position 4 in the 4-nitro-quinoid com-
pound.  
The electrophilic (electron-accepting) po-
tencies of the compounds assessed in terms of 
their LUMO energy (ϵLUMO) along with the 
electron affinity (EA) values are listed in Ta-
ble 1. This table also provides a set of reactiv-
ity indices of the compounds estimated apply-
ing the conceptual DFT (cDFT) approach 
(Geerling et al., 2003, and refs. therein). Fol-
lowing this approach, the electrophilicity in-
dex (ω), representing the global electrophilic 
power of molecules, is defined by ω = µ2/(2η) 
= (µ2/2)S where µ and η denote the electronic 
chemical potential and electronic chemical 
hardness (or softness, S = 1/η), respectively, 
which were approached in terms of HOMO 
and LUMO eigenvalues of the compounds, µ 
= (ϵLUMO + ϵHOMO)/2 and η = 1/S = ϵLUMO - 
ϵHOMO. Using this approach, the quantitative 
relationships between the hydride affinity and 
the ω index values have been defined for a 
range of para- and ortho-quinoids 
(Campodonico et al., 2009), which shows that 
this quantity can be applied to predict the ease 
of the two-electron (hydride)-reduction of 
quinoid oxidants.  
As shown in Table 1, the PNPDO, which 
differs from NPDO by the existence of an ad-
ditional nitrogen atom in the tetracyclic sys-
tem (Figure 1), possesses a higher electron-
accepting potency compared to NPDO 
quinoidal. The attachment of nitro groups to 
NPDO and PNPDO compounds substantially 
increases the electrophilic potency for nitro-
quinoidals as reflected in terms of the as-
sessed EA, ϵLUMO and ω index values (Table 
1), which vary depending on the positions of 
the nitro groups, i.e, 3-nitro- and 9-nitro-
quinoidals exhibited a markedly higher elec-
trophilic potency compared to that of 1- and 
4-nitro-quinoidals. For the whole set of the 
compounds, the approximate order of the sin-
gle- and two-electron accepting potencies 
were as follows: 3-nitro-PNPDO > 3-nitro-
NPDO ~ 9-nitro-NPDO > 1-nitro-NPDO > 4-
nitro-NPDO > PNPDO > NPDO (Table 1). 
Since, in contrast to the unsubstituted 
quinoidals, the nitro-quinoid compounds con-
tain two electron-accepting/redox-active 
sites, namely the quinone moiety and the nitro 
group, their regional electrophilic potencies 
were assessed in terms of the electrophilic Fu-
kui function (FF) values grouped over C=O 
atoms of the quinone moiety ( f +q) and N and 
O atoms of the nitro group ( f +-nitro), which 
may reflect the propensity to accept nucleo-
phile (an electron and/or an hydride ion) at the 
initial stage of the redox conversion of the 
compounds. It should be noted that for the as-
sessment of the FF values, the single  
 
Table 1: The electron affinity (EA), the LUMO energy (ϵLUMO), the electronic chemical potential index 
(µ), the chemical hardness index (η), and the electrophilic ω index values of the ortho-quinoid com-
pounds calculated by means of DFT-B3LYP functional with 6-31+G(d) basis set 
No. Compound  EA ϵLUMO µ η ω 
  eV 
1. NPDO  1.779 -3.232 -4.926 3.387 3.583 
2. PNPDO  1.951 -3.420 -5.289 3.537 3.955 
3. 1-NO2-NPDO  2.181 -3.622 -5.264 3.286 4.216 
4. 3-NO2-NPDO  2.407 -3.780 -5.425 3.284 4.481 
5. 4-NO2-NPDO  1.941 -3.622 -5.292 3.342 4.191 
6. 9-NO2-NPDO  2.434 -3.770 -5.452 3.367 4.414 
7. 3-NO2-PNPDO  2.564 -3.970 -5.664 3.414 4.699 
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point frontier molecular orbital (FMO) ap-
proach (Contreras et al., 1999) was used in 
this study as one of the most appropriate 
methods for redox active compounds which, 
in contrast to the frequently used finite-differ-
ence approximation methods, yields the posi-
tive FF values and obeys the normalization 
condition (Šarlauskas et al., 2014, and refer-
ences therein). As expected, the highest frac-
tion of the global electrophilic potency of the 
nitro-quinoidals resides upon the C=O atoms 
of the quinone moiety (the f +q values varied 
in the range of 0.42 (9-nitro-NPDO) - 0.56 (4-
nitro-NPDO)) as the most preferential site for 
the reduction of compounds, while the f+-nitro 
values of the nitro groups were assessed to be 
highly dependent upon their position: the f+-
nitro values of the coplanar (-conjugative) ni-
tro groups of 3-, 9-nitro-NPDO and 3-nitro-
PNPDO compounds (0.100, 0.149 and 0.146, 
respectively) were much higher than those of 
the twisted nitro groups of 1- and 4-nitro-
quinoidals, with f+-nitro of 0.003 and 0.004, re-
spectively, implying that the nitro groups of 
1- and 4-nitro-quinoidals, compared to 3- and 
9-nitro-quinoidals, possess a much lower ten-
dency to undergo reductive conversion. 
 
Enzymatic reactivity 
During NADPH-cytochrome P-450 re-
ductase (CPR)-mediated reactions, the time 
course of oxidation of NADPH (150 µM) by 
(P)NPDOs as well as by nitrated quinoidals 
(5-10 µM) proceeded in a single continuous 
phase (Figure not shown). The reactions were 
accompanied by concomitant oxygen uptake 
and its initial rate was supressed by 
superoxide dismutase (SOD, 150 µg mL-1) by 
30-45 %, while the introduction of catalase 
(CAT, 100 U mL-1) showed a marginal 
inhibiting effect, indicating the quinone/semi-
quinone redox cycling which yields 
superoxide. For all the compounds examined, 
the initial NADPH oxidation rates followed 
hyperbolic dependence on the varying con-
centrations of the compounds (Figure not 
shown), with kcat of 28-35 s-1 being close to 
the previously reported turnover number  
(~ 25 s-1) for FMNH--mediated reduction of 
ferricytochrome c (Čėnas et al., 1994). The 
catalytic efficiency of the reduction of the 
compounds, estimated in terms of kcat/KM, Q 
values, varied in the range of 3.1-7.2 × 107  
M-1 s-1 (Table 2) which tentatively increased 
with an increase in their electrophilic potency 
(Table 1).  
The NQO-1-mediated two-electron 
(hydride) reduction of the compounds 
proceeded with kcat of 170 - 350 s-1 and 
kcat/KM,Q values equaled to 1.6-7.4 × 108 M-1 
s-1, which were approximately ten-folds 
higher than those of CPR-mediated reduction 
of the compounds (Table 2). The kcat/KM,Q of 
these quinoidals were defined to be far higher 
than those of ortho-quinoid compounds such 
as phenanthrene ortho-quinone (9,10-PQ) 
(kcat/KM,Q of 1× 106 M-1 s-1 (Anusevičius et al., 
2002)), -lapachone and its synthetic 
analoques (kcat/KM,Q of ~ 1-3 × 106 M-1 s-1 
(Bian et al., 2014, 2015)).  
 
Table 2: The apparent second-order rate constant (kcat / KM(Q)) values of CPR and DT-diaphorase-me-
diated reduction reactions of (P)NPDO quinone compounds 
 Compound  CPR DDT 
No.   kcat/KM,Q (M-1 s-1) 
1. NPDOa  (3.1 ± 0.2) × 107 (2.4 ± 0.1) × 108 
2. PNPDOa  (3.4 ± 0.2) × 107 (1.6 ± 0.4) × 108 
3. 1-NO2-NPDO  (3.3 ± 0.5) × 107 (4.6 ± 0.7) × 108 
4. 3-NO2-NPDOa  (7.2 ± 0.5) × 107 (7.4 ± 0.3 ) × 108 
5. 4-NO2-NPDO  (4.9 ± 0.2) × 107 (4.7 ± 0.3) × 108 
6. 9-NO2-NPDOa  (5.9 ± 0.2) × 107 (3.2 ± 0.2) × 108 
7. 3-NO2-PNPDOb  (6.1 ± 0.4) × 107 (5.1 ± 0.4) × 108 
aTaken from (Šarlauskas et al., 2016) 
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Like in CPR-mediated single-electron 
tranferring reactions, the NQO-1-mediated 
oxidation of NADPH (200 µM) by 
unsubstituted as well as nitrated quinoidals 
(5-10 µM) proceeded in a single continuous 
phase, far exceeding the concentrations of the 
compounds (Figure not shown); the reactions 
were followed by the concomitant consump-
tion of O2 with rates close those of NADPH 
oxidation. The rates of O2 uptake were 
suppressed by the introduction of CAT (by ca. 
30-65 %), while SOD showed marginal 
supressing effects (~3-5 %), clearly indicating 
the generation of peroxide as a main reaction 
product.  
Measuring NQO-1-mediated reduction of 
the compounds in the presence of cytochrome 
c (50 µM) as a terminal single-electron 
acceptor, the initial rates of its reduction were 
close to the double rates of NADPH 
oxidation. In introduction of SOD partially 
supressed the rates (by ca. 30-50 %), implying 
the superoxide-mediating reduction of 
cytochrome c. In this reaction system, the 
superoxide is likely to be formed through the 
single-electron oxidation of the hydroquinon-
es by cytochrome c producing semiquinone 
radicals and their reoxidation by O2. It should 
be noted that semiquinone radicals can also be 
directly reoxidized by ferricytochrome c as it 
has previously been reported by Winterbourn 
(1981). The reoxidation of semiquinones by 
O2 and cytochrome c has been defined to fol-
low an "outer-sphere" electron transfer (ET) 
mechanism governed by the single-electron 
potential (E17) and the self-exchange rate con-
stant (kEX) values of the reactive species 
(Meyer et al., 1983; Tollin et al., 1986; Mar-
cus & Sutin, 1985). The reoxidation of sem-
iquinones by ferricytochrome c, whose kSE 
and E17(cyt c+3/cyt c+2) are equal to 5 × 105 M-
1 s-1 (Dixon et al., 1989) and + 260 mV (Rod-
key and Ball, 1950), respectively, is predicted 
to be much faster than the reoxidation of sem-
iquinones by O2, with kEX and E17(O2/O2.-) of 
~100-450 s-1 (Zahir et al., 1988) and -155 mV 
(Wardman, 1989), respectively. Thus the re-
duction of ferricytochrome c by semiquinone 
is more likely to be indirectly suppressed by 
SOD by scavenging the superoxide and thus 
lowering the concentration of semiquinone 
radical, owing to its reoxidation by O2.  
 
Antitumor activity 
The in vitro antitumor effects of the 
quinoid compounds against human tumor cell 
lines, lung carcinoma A-549, breast cancer 
MCF-7, and leukemia HL-60 cell lines were 
assessed after their 24-h treatment by varying 
concentrations of the compounds up to the 
limits of their solubility (~12.5-15 µM). The 
viability of A-549 and MCF-7 cell lines 
versus NPDO quinoidals decreased in a 
concentration-dependent manner, and the 
application of four-parametric logistic 
function provided appropriate fits to the 
experimental data (Figure 4). The estimated 
CL50 values of the compounds, causing a 
50 % lethal effect, are given in Table 3. 
Unlike A-549 and MCF-7 cells, the cytotoxic 
potency of NPDO quinoids towards HL-60 
leukemic cells was markedly lower (CL50  
> 15 µM L-1), which hampered the establish-
ment of the concentration-response curves 
and, consequently, the assessment of CL50 
values (Figure not shown). As shown in Table 
3, the cytotoxic potency of the whole set of 
the quinoid compounds towards MCF-7 
(CL50 = 0.08 - 2.74 µM L-1) was in general 
higher than their potency against A-549 cell 
line, with CL50 values of 0.28-7.66 µM L-1, 
except for 3-nitro-NPDO, whose activity 
against A-549 (CL50 = 0.12 ± 0.03 µM L-1) 
was approximately twice as high as that on 
MCF-7 cell line (CL50 = 0.27 ± 0.08 µM L-1).
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Figure 4: The dependence of viability of A-549 and MCF-7 tumor cells upon the varying concentrations 
of NPDO and PNPDO quinoidals. The cell survival was assessed by means of MTT assay and 
expressed as percentages relative to the 0.1 % DMSO -treated cells used as control. Each point 
represents the mean of the experiments performed in triplicate and the vertical bars the standard error 
of the mean (S.E.M). The data were analyzed by nonlinear regression analysis by using the logistic type 
concentration-responce curve.  
 
 
Table 3: Cytotoxic effects of ortho-quinoids against A-549, MCF-7 and HL-60 cell lines (results are 
shown as the mean ± S.E.M.) 
No. Compound A-549 MCF-7 HL-60 
  CL50 (µM L-1)  
1. NPDOa 0.67 ± 0.16 0.51 ± 0.13 > 15 
2. PNPDOa 1.59 ± 0.28 0.78 ± 0.27 >15 
3. 1-NO2-NPDO 7.01 ± 0.50 2.02 ± 0.47 > 15 
4. 3-NO2-NPDOa 0.12 ± 0.03 0.28 ± 0.08 > 15 
5. 4-NO2-NPDO 7.66 ± 0.73 2.74 ± 0.85 > 15 
6. 9-NO2-NPDOa 2.30 ±0.65 1.70 ± 0.10 > 15 
7. 3-NO2-PNPDO 1.15 ± 0.48 0.076 ± 0.010 > 15 
aTaken from (Šarlauskas et al., 2016) 
 
 
 
Compared to NPDO quinoidal, PNPDO, 
possessing a higher electrophilic potency, ex-
hibited lower antitumor activity against both 
A-549 and MCF-7 cell lines (Table 3). The at-
tachment of nitro group at position 3 of the 
benzene ring of PNPDO quinoidal signifi-
cantly enhanced the cytotoxic potency of 3-
nitro-PNPDO against MCF-7 cell line, with 
CL50 value of 0.076 ± 0.010 µM L-1 being 10-
folds higher than that of its precursor (CL50 = 
0.78 ± 0.27 µM L-1), while activity of 3-nitro-
PNPDO on A-549 cell line (CL50 of 1.15 ± 
0.48 µM L-1) was only slightly higher com-
pared to its precursor (CL50 =1.59 ± 0.28 µM 
L-1). Virtually the same was observed for 3-
nitro-NPDO quinoidal, whose cytotoxic ef-
fects on A-549 cell line (CL50 = 0.120 ± 0.03 
µM L-1) and MCF-7 cells (CL50 = 0.280 ± 
0.08 µM L-1) were approximately 6- and 2-
folds higher, respectively, than those of 
NPDO compound. In contrast to 3-nitro- and 
9-nitro-NPDOs, the attachment of the nitro 
group at the positions 1 and 4 of NPDO ben-
zene ring markedly decreased the cytotoxic 
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potency of 1-nitro- and 4-nitro-quinoidals to-
wards A-549 cell line and to a lesser degree 
on MCF-7 cell line when compared to NPDO, 
as evidenced in Figure 4 and listed in Table 3. 
These data show, that, in general, the 3- and 
9-nitro substituted quinoids with planar nitro 
groups and thus higher electrophilic potency 
for their single- and two-electron (hydride) re-
duction, as defined in terms of EA, ϵLUMO and 
ω index values, respectively, exhibited mark-
edly higher antitumor activity as compared to 
that of the 1- and 4-nitro-quinoidals with non-
planar nitro groups and lower electrophilic 
potency. In contrast to the unsubstituted or-
tho-quinones, the nitro-quinone compounds 
bearing a nitro group as an additional electro-
philic site may experience more complex met-
abolic conversion. The (cyto)toxic action of 
nitro-based xenobiotics and drug agents is fre-
quently related to their reductive activation, 
i.e, single-electron reduction to the free radi-
cals followed by ROS generation and/or two-
/four-electron reduction of the nitro groups 
yielding highly reactive nitroso-/hydroxyla-
mine intermediates (Tocher, 1997; Knox and 
Chen, 2004; Chen and Hu, 2009, and refs. 
therein). The position and the geometry of the 
nitro groups have been reported to be im-
portant structural features of the nitro-based 
xenobiotics in their cytotoxic activity, i.e, the 
compounds with planar nitro groups have 
been observed to be more effective cytotoxic 
agents than their isomers bearing non-planar 
nitro groups (Onchoke et al., 2004; Taka-
mura-Enya et al., 2006). As reported above, 
the assessed electrophilic Fukui function val-
ues showed that the highest fraction of the 
electrophilic potency of nitro-quinoidals re-
sides upon the C=O atoms, suggesting that the 
cytotoxic activity of the compounds is most 
likely to be due to the redox action of their 
quinone moiety; however, a relatively high 
regional electrophilic potency was also de-
fined for the nitro groups of the 3- and 9-nitro-
quinoidals, which implies that their nitro 
groups can be involved in cytotoxic action.  
To estimate the mode of cell death in-
duced by the ortho-quinoidals, the tumor cells 
treated with the most active quinoid com-
pounds were quantified applying the dual 
EB/EO fluorescence staining approach. As 
shown in Figure 5A and B, 0.1 % DMSO-
treated A-549 and MCF-7 tumor cells used as 
controls showed 93-95 % viable cells (highly 
condensed bright green chromatin), 2-3 % 
viable apoptotic (bright green nucleus with 
condensed/fragmented chromatin), ~ 3 % late 
apoptotic (condensed and fragmented orange 
chromatin), and 1-2 % necrotic cells (non-
fragmented red nucleous), respectively. After 
24 h treatment, NPDO and 3-nitro-NPDO 
quinoidals, at their CL50 concentrations 
(Table 3), diminished the viable cells to 47-
50 % (A-549) and 30-45 % (MCF-7), respect-
ively, and increased the apoptotic cells (34-
38 % (A-549) and 30-45 % (MCF-7) viable 
apoptotic and 11-15 % (A-549) and 9-12 % 
(MCF-7) nonviable apoptotic), while the 
percentages of the necrotic cells in both cell 
lines were virtually the same as those in the 
untreated cells, implying that the tumor cell 
death induced by the treatment of NPDO 
quinoidals occurs primarily through apop-
tosis. 
 
CONCLUDING REMARKS 
The nitrogen-containing tetracyclic ortho-
quinones and their nitrated derivatives serve 
as excellent electron-accepting and redox ac-
tive substrates of single- and two-electron 
(hydride)-transferring electron transferring 
flavoenzymes CPR and NQO-1, respectively, 
generating reactive oxygen species, and dis-
played relatively high antitumor potency. The 
antitumor activities of nitro-quinoidals were 
observed to be dependent upon the position of 
nitro groups added to the tetracyclic system; 
3- and 9-nitro-quinoidals having the highest 
electron-accepting potency and being virtu-
ally the most efficient enzymatic substrates, 
showed the highest antitumor effects while 1- 
and 4-nitro-quinoidals produced the least 
anti-tumor activities. The assessment of the 
electrophilic Fukui function values implies  
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Figure 5: A) Morphological changes of A-54 tumor cells upon 24-h treatment by CL50 concentrations of 
NPDO and 3-nitro-NPDO quinoidals, quantified by means of AO/EB staining (viable cells (solid arrows), 
viable apoptotic (dashed-dot arrows), nonviable apoptotic (dotted arrows), and necrosis cells (dashed 
arrows)). B) The percentage of viable, apoptotic and necrotic cells of A-549 and MCF-7 tumor cells upon 
the treatment by NPDO and 3-nitro-NPDO. Data represent the mean of at least three independent ex-
periments. 
 
 
 
that ortho-quinone moiety of the compounds 
is essential for their redox action inducing cy-
totoxic effects; however, a relatively high lo-
cal electrophilic potency defined for nitro 
groups of the 3- and 9-nitro-quinoidals sug-
gests that their nitro groups might be also in-
volved in cytotoxic action. The data obtained 
about the structures of (P)NPDOs, global and 
regional reactivities, and their antitumor 
activities provide some guide for synthesis of 
related structure compounds as antitumor 
agents. 
 
Acknowledgement 
The authors are highly grateful for the fi-
nancial support of the Scientific Council of 
Lithuania (the project No. MIP-032/2014). 
The authors thank Audrius Laurynėnas (Vil-
nius University, Center of Life Science) for 
his excellent assistance in DFT computation. 
The authors also thank Lina Marčiulionytė 
(Lecturer at Vilnius University) for proof-
reading the manuscript. 
 
Conflict of interest 
The authors declare no conflict of interest. 
EXCLI Journal 2017;16:663-678 – ISSN 1611-2156 
Received: March 14, 2017, accepted: April 29, 2017, published: May 11, 2017 
 
 
676 
REFERENCES 
Anusevičius Ž, Šarlauskas J, Čėnas N. Two-electron 
reduction of quinones by rat liver NAD(P)H:quinone 
oxidoreductase: quantitative structure-activity relat-
ionships. Arch Biochem Biophys. 2002;404:254-62.  
Asche C. Antitumor quinones. Mini Rev Med Chem. 
2005;5:449-67. 
Bachur N, Gordon SL, Gee MV, Kon H. NADPH cy-
tochrome P-450 reductase activation of quinone anti-
cancer agents to free radicals. Proc Natl Acad Sci USA. 
1979;76:954-7. 
Beall HD, Winski SL. Mechanism of action of qui-
none-containing alkylating agents I: NQO1-directed 
drug development. Front Biosci. 2000;5:639-48.  
Bian J, Deng B, Xu L, Xu X, Wang N, Hu T, et al. 2-
substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as 
novel L-shaped ortho-quinone substrates for NAD(P) 
H:quinones oxidoreductase (NQO1). Eur J Med Chem. 
2014;82:56-67. 
Bian J, Xu L, Deng B, Qian X, Fan J, Yang X, et al. 
Synthesis and evaluation of (+/-)-dunione and its ortho-
quinone analogues as substrates for NAD(P)H:quinone 
oxidoreductase 1 (NQO1). Bioorg Med Chem Lett. 
2015;25:1244-8.  
Bolton JL, Dunlap T. Formation and biological targets 
of quinones: cytotoxic versus cytoprotective effects. 
Chem Res Toxicol. 2017;30:13-37.  
Bolton JL, Trush MA, Penning TM, Dryhurst G, 
Monks TJ. Role of quinones in toxicology. Chem Res 
Toxicol. 2000;13:135-60.  
Borges RS, Carneiro AS, Barros TG, Barros CA, 
Chalves Neto AMJ, da Silva ABF. Understanding the 
cytotoxicity or cytoprotective effects of biological and 
synthetic quinone derivatives by redox mechanism. J 
Mol Model. 2014;20:2541-6.  
Brandy Y, Ononiwu I, Williams V, Mouamba C, Ka-
naan Y, Copeland RL Jr, et al. Synthesis and cytotoxic 
activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-di-
one derivatives on androgen-dependent (LNCaP) and 
androgen-independent (PC3) human prostate cancer 
lines. Invest New Drugs. 2012;30:1709-14.  
Cai Y, Zhang W, Chen Z, Shi Z, He C, Chen M. Recent 
insights into biological activities and drug delivery sys-
tems of tanshinones. Int J Nanomed. 2016;11:121-30.  
Campodonico PR, Aizman A, Contreras R. Electro-
philicity of quinones and its relationships with hydride 
affinity. Chem Phys Lett. 2009;471:168-73. 
Chen Y, Hu L. Drug of anticancer prodrugs for reduc-
tive activation. Med Chem Rev. 2009;1:29-37.  
Čėnas N, Anusevičius Ž, Bironaitė D, Bachmanova G, 
Archakov A, Ollinger K. The electron transfer reac-
tions of NADPH:cytochrome P450 reductase with non-
physiological oxidants. Arch Biochem Biophys. 1994; 
3115:400-6.  
Colucci M, Couch GD, Moody CJ. Natural and syn-
thetic quinons and their reduction by quinone reductase 
enzyme NQO1: from synthetic organic chemistry to 
compounds with anticancer potential. Org Biomol 
Chem. 2008;6:637-56.  
Contreras RR, Fuentealba P, Galván M, Perez P. A di-
rect evaluation of regional Fukui functions in mole-
cules. Chem Phys Lett. 1999;304:405-13. 
Dang Y, Morris-Natschke SL, Lee KH. Biosynthesis, 
total syntheses, and antitumor activity of tanshinones 
and their analogs as potential therapeutic agents. Nat 
Prod Rep. 2011;28:529-42.  
Danson S, Ward TH, Butler J, Ranson M. DT-diapho-
rase: a target for new anticancer drugs. Cancer Treat 
Rev. 2004;30:437-49.  
Deegan C, Coyle B, McCann M, Egan DA. In vitro 
anti-tumour effect on 1,10-phenanthroline-5,6-dione 
(phendione), [Cu(phendione)3](ClO4)2,4H2O and 
[Ag(phendione)2]ClO4 using human epithelial cell 
lines. Chem Biol Interact. 2006;164:115-25.  
Delgrado V, Ibacache A, Theoduloz C, Valderamma 
JA. Synthesis and in vitro cytotoxic evaluation of ami-
noquinones structurally related to marine isoquinoil-
inequinones. Molecules. 2012;17:7042-56.  
Dixon DW, Hong X, Woehler SE. Electrostatic and 
steric control of electron self-exchange in cytochrome 
c, c551 and b5. Biophys J. 1989;56:339-51.  
Garuti L, Roberti M, Pizzirani D. Nitrogen-containing 
heterocyclic quinones: a class of potential selective an-
titumor agents. Mini Rev Med Chem. 2007;7:481-9.  
Geerling P, de Proft F, Langeneker W. Conceptual den-
sity functional theory. Chem Rev. 2003;103:1793-873. 
Gutierrez PL. The metabolism of quinone-containing 
alkylating agents: free radical production and measure-
ment. Front Biosci. 2000;5:629-38. 
Joseph P, Long DJ Jr, Klein-Szanto AJ, Jaiswal A. 
Role of NAD(P)H:quinone oxidoreductase 1 (DT-di-
aphorase) in protection against quinone toxicity. Bio-
chem Pharmacol. 2000;60:207-14.  
EXCLI Journal 2017;16:663-678 – ISSN 1611-2156 
Received: March 14, 2017, accepted: April 29, 2017, published: May 11, 2017 
 
 
677 
Knox RJ, Chen S. Quinone reductase mediated nitro-
reduction: clinical application. Methods Enzymol. 
2004;382B:194-221.  
Kolm RH, Danielson UH, Zhang Y, Talalay P, Manne-
vrik B. Isothiocyanates as substrates for human gluta-
thione transferase: Structure-activity studies. Biochem 
J. 1995;311:453-9.  
Koyama J, Morita I, Yamori T. correlation between cy-
totoxic activities and reduction potentials of heterocy-
clic quinones. Molecules. 2010;15:6559-69.  
Liou GY, Storz P. Reactive oxygen species in cancer. 
Free Radic Res. 2010;44:479-96.  
Marcus RA, Sutin N. Electron transfers in chemistry 
and biology. Biochim Biophys Acta 1985;811:265-
322.  
Mates JM, Sanchez-Jimenez FM. Role of reactive ox-
ygen species in apoptosis: implications for cancer ther-
apy. Int J Biochem Cell Biol. 2000;32:157-70.  
Matsuda H, Kimura S, Iyanagi T. One-electron reduc-
tion of quinones by the neuronal nitric-oxide synthase 
reductase domain. Biochim Biophys Acta. 2000;1459: 
106-16.  
Meyer TE, Przysiecki CT, Watkins JA, Bhattacharyya 
A., Simondsen RP, Cusanovich MA, et al. Correlation 
between rate constant for reduction and redox poten-
tial as a basis for systematic investigation of reaction 
mechanism of electron transfer proteins. Proc Natl 
Acad Sci USA. 1983;80:6740-4. 
Monks TJ, Jones DS. The metabolism and toxicity of 
quinones, quinonimines, quinone methides, and qui-
none-thioethers. Curr Drug Metabol. 2002;3:425-38. 
Monks T, Hanzlik RP, Cohen GM, Ross D, Graham 
DG. Contemporary issues in toxicology. Quinones 
chemistry and toxicity. Toxicol Appl Pharmacol. 1992; 
112:2-16.  
Nohl H, Werner J, Younman R. Quinones in biology: 
functions in electron transfer system and oxygen acti-
vation. Adv Free Rad Biol Med. 1986;2:211-79. 
Onchoke KK, Hadad CM, Dutta PK. Density func-
tional theoretical study of nitrated polycyclic arimatic 
hydrocarbons. Polyaromat Comp. 2004;24: 37-64. 
Pan SS, Andrew PA, Glover CJ. Reductive activation 
of mitomycin C and mitomycin C metabolites cata-
lyzed by NADPH-cytochrome P-450 reductase and 
xanthine oxidase. J Biol Chem. 1993;259:959-66.  
Pechurskaja TA, Harnastai IN, Grabovec IP, Gilep AA, 
Usanov SA. Adrenodoxin supports reactions catalyzed 
by microsomal steroidgenetic cytochrome P450s. Bio-
chem Biophys Res Commun. 2007;353:598-604. 
Powis G. Free radical formation by antitumor quin-
ones. Free Radic Biol Med. 1989;6:63-101. 
Prochaska HJ. Purification and crystallization of rat 
liver NAD(P)H:quinone-acceptor oxidoreductase by 
cibacron blue affinity chromatography: Identification 
of a new and potent inhibitor. Arch Biochem Biophys. 
1988;267:529-38.  
Riffel A, Medina LF, Stefani V, Santos RC, Bizani D, 
Brandelli A. In vitro antimicrobial activity of a new 
series of 1,4-naphthoquinones. Braz J Med Biol Res. 
2002;35:811-8. 
Rodkey FL, Ball EG. Oxidation-reduction potentials of 
the cytochrome c systems. J Biol Chem. 1950;182:17-
28.  
Rooseboom M, Commandeur JMN, Vermeulen NPE. 
Enzyme-catalyzed activation of anticancer pro-drugs. 
Pharmacol Rev. 2004;56:53-102.  
Ross D, Beall H, Traver R, Siegel D, Gustafson DL. 
Enzymology of bioreductive drug activation. Br J Can-
cer Suppl. 1996;27:S1-8.  
Shankar BS, Panday RP, Amin P, Misra HS, Sainis 
KB. Role of glutathione is augmenting the anticancer 
activity of pyrroloquinoline quinone (PQQ). Redox 
Report. 2010;15. 
Shen YD, Tian YX, Bu XZ, Gu LQ. Natural tanshione-
like heterocyclic-fused ortho-quinones from regiose-
lective Diels-Alder reactions: Synthesis and cytotoxic 
evaluation. Eur J Med Chem. 2009;44:3915-21. 
Siegel D, Yan C, Ross D. NAD(P)H:quinone oxidore-
ductase 1 (NQO1) in the sensitivity and resistance of 
antitumor quinones. Biochem Pharmacol. 2012;83: 
1033-40. 
Šarlauskas J, Misevičienė L, Marozienė A, Karvelis L, 
Stankevičiūtė J, Krikštopaitis K, et al. The study of 
NADPH-dependent flavoenzyme-catalyzed reduction 
of benzo[1,2-c]1,2,5-oxadiazole N-oxides (benzofuro-
xans). Int J Mol Sci. 2014;15:23307-31. 
Šarlauskas J, Pečiukaitytė-Alksnė M, Misevičienė L, 
Marozienė A, Polmickaitė E, Staniulytė Z, et al. Naph-
tho[1',2':4,5]imidazo[1,2-a]pyridine-5,6-diones. Bio-
org Med Chem Lett. 2016;26:512-7.  
Takamura-Enya T, Suzuki H, Hisamatsu Y. Mutagenic 
activities and physicochemical properties of selected 
nitrobenzathrones. Mutagenesis. 2006;21:399-404.  
EXCLI Journal 2017;16:663-678 – ISSN 1611-2156 
Received: March 14, 2017, accepted: April 29, 2017, published: May 11, 2017 
 
 
678 
Tocher JH. Reductive activation of nitroheterocyclic 
compounds. Gen Pharmacol. 1997;28:485-7.  
Tollin G, Meyer T, Cusanovich MA. Elucidation of the 
factors which determine reactions rate constants and 
biological specificity for electron transfer proteins. Bi-
ochim Biophys Acta. 1986;853:29-41. 
Tonholo J, Freitas LR, de Abreu FC, Azevedo DC, 
Zani CL, de Oliveira AB, et al. Electrochemical prop-
erties of biologically active heterocyclic nathphoqui-
nones. J Braz Chem Soc. 1998;9:163-9.  
Valderrama JA, Colonelli P, Vasquez D, Gonzalez MF, 
Rodriquez JA, Theoduloz C. Studies on quinones. Part 
44: Novel angucyclinone N-heterocyclic analogues en-
dowed with antitumor activity. Bioorg Med Chem. 
2008;15:10172-81.  
Vásquez D, Rodríguez JA, Theoduloz C, Calderon PB, 
Valderrama JA. Studies on quinones. Part 46. Synthe-
sis and in vitro antitumor evaluation of aminopyrimid 
oisoquinoilinequinones. Eur J Med Chem. 2010;45: 
5234-42. 
Wardman P. Reduction potentials of one-electron cou-
ples involving free radicals in aqueous solution. J Phys 
Chem Ref Data. 1989;18:1637–755. 
Winterbourn CC. Cytochrome c reduction by semiqui-
none radicals can be indirectly inhibited by superoxide 
dismutase. Arch Biochem Biophys. 1981;209:159-67.  
Zahir K, Espenson JH, Bakac A. Reactions of polypyr-
idilchromium (II) ions with oxygen: determination of 
the self-exchange rate constant of ogygen O2/O2. J Am 
Chem Soc. 1988;110:5059-63.  
Zhang Y, Jiang P, Ye M, Kim S-H, Jiang C, Lu J. 
Tanshinones: saurces, pharmacokinetics and anti-
cancer activities. Int J Mol Sci. 2012;13:13621-66.  
